Dyne Therapeutics Inc (DYN)

Dec 19, 2024

Barclays PLC Purchases 128,246 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 19, 2024

Dec 19, 2024

Wellington Management Group LLP Reduces Stock Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 19, 2024

Dec 18, 2024

Franklin Resources Inc. Cuts Stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 18, 2024

Dec 15, 2024

State Street Corp Raises Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 15, 2024

Dec 14, 2024

Dyne Therapeutics (NASDAQ:DYN) Shares Gap UpWhat's Next? - MarketBeat

Dec 14, 2024

Dec 14, 2024

Dyne Therapeutics initiated with Outperform at Baird - MSN

Dec 14, 2024

Dec 14, 2024

Dyne Therapeutics (NASDAQ:DYN) Upgraded at Raymond James - MarketBeat

Dec 14, 2024

Dec 13, 2024

How to Take Advantage of moves in (DYN) - Stock Traders Daily

Dec 13, 2024

Dec 13, 2024

Baird Initiates Coverage of Dyne Therapeutics (DYN) with Outperform Recommendation - MSN

Dec 13, 2024

Dec 13, 2024

Dyne Therapeutics (NASDAQ:DYN) Now Covered by Robert W. Baird - MarketBeat

Dec 13, 2024

Dec 13, 2024

29,694 Shares in Dyne Therapeutics, Inc. (NASDAQ:DYN) Acquired by Y Intercept Hong Kong Ltd - MarketBeat

Dec 13, 2024

Dec 12, 2024

DYN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Dyne Therapeutics, Inc. and Encourages Investors to Contact the Firm! - The Eastern Progress Online

Dec 12, 2024

Dec 12, 2024

Baird sets $46 target on Dyne Therapeutics, sees upside By Investing.com - Investing.com UK

Dec 12, 2024

Dec 12, 2024

Dyne therapeutics SVP Richard Scalzo sells $40,914 in stock By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 12, 2024

Dyne therapeutics SVP Richard Scalzo sells $40,914 in stock - Investing.com India

Dec 12, 2024

Dec 11, 2024

Dyne therapeutics' chief scientific officer sells $65,632 in stock By Investing.com - Investing.com UK

Dec 11, 2024

Dec 11, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - The Eastern Progress Online

Dec 11, 2024

Dec 09, 2024

Point72 Asset Management L.P. Sells 255,038 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 09, 2024

Dec 08, 2024

The Manufacturers Life Insurance Company Sells 20,029 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 08, 2024

Dec 06, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Position Boosted by Charles Schwab Investment Management Inc. - MarketBeat

Dec 06, 2024

Dec 05, 2024

Dyne Therapeutics (DYN) Stock Drops Amidst Biotech Sector Moveme - GuruFocus.com

Dec 05, 2024

Dec 05, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock Holdings Boosted by RTW Investments LP - MarketBeat

Dec 05, 2024

Dec 05, 2024

RA Capital Management L.P. Grows Stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 05, 2024

Dec 05, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives $50.82 Consensus Target Price from Analysts - MarketBeat

Dec 05, 2024

Dec 04, 2024

Janus Henderson Group PLC Raises Stock Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 04, 2024

Dec 03, 2024

HighVista Strategies LLC Makes New $2.35 Million Investment in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 03, 2024

Dec 03, 2024

Holocene Advisors LP Sells 93,712 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 03, 2024

Dec 03, 2024

Piper Sandler maintains $53 target on Dyne Therapeutics stock By Investing.com - Investing.com Canada

Dec 03, 2024

Dec 01, 2024

Fmr LLC Has $324.24 Million Stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Dec 01, 2024

Nov 30, 2024

Dyne Therapeutics (NASDAQ:DYN) Shares Down 4.2%Time to Sell? - MarketBeat

Nov 30, 2024

Nov 30, 2024

Eventide Asset Management LLC Sells 152,723 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 30, 2024

Nov 29, 2024

Intech Investment Management LLC Purchases New Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 29, 2024

Nov 28, 2024

Myotonic dystrophy pipeline shows momentum - The Pharma Letter

Nov 28, 2024

Nov 28, 2024

Acuta Capital Partners LLC Sells 166,300 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 28, 2024

Nov 27, 2024

Myotonic Dystrophy Clinical Trial Pipeline Boom as Over 20 Companies Leading the Charge in Research and Development | DelveInsight - The Malaysian Reserve

Nov 27, 2024

Nov 27, 2024

Connor Clark & Lunn Investment Management Ltd. Invests $1.48 Million in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 27, 2024

Nov 27, 2024

Victory Capital Management Inc. Purchases 11,385 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World

Nov 27, 2024

Nov 26, 2024

Dyne, Avidity initiated at outperform by RBC on DM1 drugs (NASDAQ:DYN) - Seeking Alpha

Nov 26, 2024

Nov 26, 2024

Dyne Therapeutics (NASDAQ:DYN) Coverage Initiated at Royal Bank of Canada - MarketBeat

Nov 26, 2024

Nov 26, 2024

RBC Capital starts Dyne Therapeutics shares at Outperform, targets genetic medicine success - Investing.com UK

Nov 26, 2024

Nov 26, 2024

Principal Financial Group Inc. Reduces Stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World

Nov 26, 2024

Nov 25, 2024

Susanna High named CEO of Paragon - BioCentury

Nov 25, 2024

Nov 22, 2024

Dyne Therapeutics Inc. (DYN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey

Nov 22, 2024

Nov 22, 2024

Jennison Associates LLC Has $48.38 Million Stock Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 22, 2024

Nov 21, 2024

DYN (Dyne Therapeutics) 9-Day RSI : 49.47 (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Dyne Therapeutics director Incerti Carlo sells $474,045 in stock - Investing.com India

Nov 20, 2024